PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
17.63
Positive P/E while Healthcare median is negative at -1.13. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
2.27
P/S less than half the Healthcare median of 6.41. Walter Schloss would verify if this discount reflects fixable issues. Check margins versus peers.
2.24
P/B 1.1-1.25x Healthcare median of 1.88. John Neff would demand superior ROE to justify premium.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.24
Fair value ratio 1.1-1.25x Healthcare median of 1.89. John Neff would demand superior metrics to justify premium.
1.42%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
No Data
No Data available this quarter, please select a different quarter.